U.S. markets closed

Aileron Therapeutics, Inc. (ALRN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.3600+0.0200 (+1.49%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 9/18/2020
Current
6/30/20203/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
52.61M46.33M9.23M15.94M18.64M19.23M
Enterprise Value 3
38.94M38.56M-4.01M-3.49M-7.66M11.28M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/AN/A
Price/Book (mrq)
3.164.740.580.700.621.50
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/AN/A
Enterprise Value/EBITDA 6
-1.48-8.900.590.480.97-1.53

Trading Information

Stock Price History

Beta (5Y Monthly) 3.62
52-Week Change 345.92%
S&P500 52-Week Change 310.95%
52 Week High 31.9900
52 Week Low 30.2500
50-Day Moving Average 31.2584
200-Day Moving Average 30.8950

Share Statistics

Avg Vol (3 month) 3835.61k
Avg Vol (10 day) 3497.8k
Shares Outstanding 539.26M
Float 21.28M
% Held by Insiders 126.52%
% Held by Institutions 116.29%
Shares Short (Aug 30, 2020) 4802.05k
Short Ratio (Aug 30, 2020) 40.52
Short % of Float (Aug 30, 2020) 42.44%
Short % of Shares Outstanding (Aug 30, 2020) 42.04%
Shares Short (prior month Jul 30, 2020) 4609.61k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-50.02%
Return on Equity (ttm)-112.02%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-17.66M
EBITDA -26.3M
Net Income Avi to Common (ttm)-26.12M
Diluted EPS (ttm)-0.9100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)18.88M
Total Cash Per Share (mrq)0.48
Total Debt (mrq)5.21M
Total Debt/Equity (mrq)31.26
Current Ratio (mrq)3.99
Book Value Per Share (mrq)0.42

Cash Flow Statement

Operating Cash Flow (ttm)-24.02M
Levered Free Cash Flow (ttm)-14.69M